STOCK TITAN

Corbus Pharmaceu (CRBP) Free Cash Flow by Year

CRBP

Corbus Pharmaceu recorded an outflow of $64.5M in free cash flow in fiscal year 2025. This represents a decrease of 54.3% from the prior fiscal year. The table below carries 13 fiscal years, from 2013 to 2025, and the quarters Corbus Pharmaceu has filed alongside them.

FY2025 annual
Free Cash Flow -$64.5M
YoY -54.3%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

CRBP Free Cash Flow by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-K
Free Cash Flow-$64.5M-54.3%-$41.8M-15.8%-$36.1M+3.9%-$37.6M+22.1%-$48.2M+51.8%-$100.2M-106.7%-$48.5M-49.7%-$32.4M-13.6%-$28.5M-104.7%-$13.9M-193.8%-$4.7M-95.4%-$2.4MN/A

CRBP Free Cash Flow by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Free Cash Flow-$29.6M-78.5%-$25.6M-55.8%N/AN/A-$16.6M-$16.4MN/AN/AN/AN/A-$6.0M+19.4%-$7.2M+1.0%

What free cash flow means

Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper.

More Corbus Pharmaceu financials

Frequently Asked Questions

What was Corbus Pharmaceu's free cash flow in fiscal year 2025?

Corbus Pharmaceu recorded an outflow of $64.5M in free cash flow in fiscal year 2025.

How fast is Corbus Pharmaceu's free cash flow growing?

Corbus Pharmaceu (CRBP) free cash flow fell by 54.3% year over year, from -$41.8M to -$64.5M in fiscal year 2025.

What was Corbus Pharmaceu's free cash flow in the most recent quarter?

Corbus Pharmaceu (CRBP) reported -$29.6M in free cash flow in Q2 2026. This represents a decrease of 78.5% from the same quarter a year earlier.

Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper. This page lists what Corbus Pharmaceu (CRBP) reported on that line in every period on record.